SCHEMBL2774016

SCHEMBL2774016

COc1ccccc1C#Cc1ccccc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 1/20 0.60
MEN1 O00255 2/20 0.55
KMT2A Q03164 2/20 0.55
ALDH1A1 P00352 2/20 0.55
MAPT P10636 2/20 0.55
NPC1 O15118 2/20 0.55
KDM4E B2RXH2 1/20 0.55
CYP1A2 P05177 1/20 0.55
CYP3A4 P08684 1/20 0.55
CYP2C9 P11712 1/20 0.55
HPGD P15428 1/20 0.55
CYP2C19 P33261 1/20 0.55
SMN1; SMN2 Q16637 1/20 0.55
HSD17B10 Q99714 1/20 0.55
GRM5 P41594 2/20 0.50
KCNH2 Q12809 1/20 0.50
APP P05067 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.49
CA12 O43570 2/20 0.48
CA2 P00918 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30022461 0.89 CA1 (0.60) FFAR1MEN1KMT2AALDH1A1MAPT
SCHEMBL4214499 0.89 CA1 (0.60) FFAR1MEN1KMT2AALDH1A1MAPT
SCHEMBL8083186 0.88 FFAR1 (0.57) FFAR1MEN1KMT2AALDH1A1MAPT
SCHEMBL28352734 0.86 FFAR1 (0.56) FFAR1MEN1KMT2AALDH1A1MAPT
SCHEMBL28353258 0.86 APP (0.58) FFAR1MEN1KMT2AALDH1A1MAPT
SCHEMBL28353255 0.86 FFAR1 (0.56) FFAR1MEN1KMT2AALDH1A1MAPT
SCHEMBL28356528 0.85 FFAR1 (0.55) FFAR1MEN1KMT2AALDH1A1MAPT
SCHEMBL14958068 0.85 KCNH2 (0.49) FFAR1MEN1KMT2AALDH1A1MAPT
SCHEMBL28353254 0.85 FFAR1 (0.55) FFAR1MEN1KMT2AALDH1A1MAPT
SCHEMBL28353226 0.83 GRM5 (0.49) FFAR1MEN1KMT2AALDH1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117845235-A Preparation method of cis-stilbene compound 深圳市环保科技集团股份有限公司 2024-04-09 CN claimed
CN-110372653-B Selenylation benzofuran compound and synthesis method thereof 温州大学 2022-11-15 CN claimed
US-11351126-B2 Substituted tolans for the modulation of microbial colonization BioMendics, LLC (US) 2022-06-07 US claimed
CN-110791775-B Method for continuously preparing 2-aryl-benzothiophene/furan compounds by using electrochemical microchannel reaction device 南京工业大学 2021-02-05 CN claimed
CN-110760877-B Method for continuously preparing 2-aryl-3-halogenated-benzofuran compound by using electrochemical microchannel reaction device 南京工业大学 2021-01-29 CN claimed
CN-111526873-A Substituted tolanes for regulating microbial colonization 生物曼迪克斯有限责任公司 2020-08-11 CN claimed
US-20200206154-A1 Substituted Tolans for the Modulation of Microbial Colonization BioMendics, LLC (US) 2020-07-02 US claimed
EP-3658128-A1 SUBSTITUTED TOLANS FOR THE MODULATION OF MICROBIAL COLONIZATION Biomendics, LLC (US) 2020-06-03 EP claimed
CN-110791775-A Method for continuously preparing 2-aryl-benzothiophene/furan compounds by using electrochemical microchannel reaction device 南京工业大学 2020-02-14 CN claimed
CN-110760877-A Method for continuously preparing 2-aryl-3-halogenated-benzofuran compound by using electrochemical microchannel reaction device 南京工业大学 2020-02-07 CN claimed
WO-2019023425-A1 SUBSTITUTED TOLANS FOR THE MODULATION OF MICROBIAL COLONIZATION BioMendics, LLC (US) 2019-01-31 WO claimed
WO-2024261504-A1 BENZOFURAN-3-CARBOXYLIC ACID AMIDES AND BENZOFURAN-3- CARBONYL-BENZAMIDES, METHOD FOR THEIR PRODUCTION WITH HIGH SELECTIVITY, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM PÉCSI TUDOMÁNYEGYETEM (HU) 2024-12-26 WO disclosed
US-20240237383-A1 ORGANIC ELECTROLUMINESCENT DEVICE SFC CO., LTD. (KR) 2024-07-11 US disclosed
CN-111856878-B Resist underlayer composition and method for forming pattern using the same 罗门哈斯电子材料有限责任公司 2024-04-12 CN disclosed
CN-117845235-A Preparation method of cis-stilbene compound 深圳市环保科技集团股份有限公司 2024-04-09 CN disclosed
US-7642391-B1 Palladium-catalyzed coupling of aryl halides with alkynes IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2010-01-05 US disclosed
US-7105374-B1 Memory cell containing copolymer containing diarylacetylene portion SPANSION LLC (US) 2006-09-12 US disclosed
EP-0171209-B1 ACETYLENIC PHENOXYPROPANOL DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HYPERTENSION McNeilab, Inc. (US) 1989-03-01 EP disclosed
US-4652584-A Acetylenic phenoxypropanol derivatives and pharmaceutical compositions for the treatment of hypertension MCNEILAB, INC. (US) 1987-03-24 US disclosed
EP-0171209-A1 Acetylenic phenoxypropanol derivatives and pharmaceutical compositions for the treatment of hypertension McNeilab, Inc. (US) 1986-02-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200206154-A1 Substituted Tolans for the Modulation of Microbial Colonization LMAN1, DPM1, DSTN FFAR1 350/4885MEN1 3825/4885KMT2A 3977/4885
US-11351126-B2 Substituted tolans for the modulation of microbial colonization LMAN1, DPM1, DSTN FFAR1 350/4885MEN1 3825/4885KMT2A 3977/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.